Determination of Radiation Absorbed Dose to Primary Liver Tumors and Normal Liver Tissue Using Post-Radioembolization 90Y PET

Intraprocedural Yttrium-90 Positron Emission Tomography/CT for Treatment Optimization of Yttrium-90 Radioembolization

(2014) Austin C. Bourgeois et al.   JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY

A Comparison of Techniques for 90Y PET/CT Image-Based Dosimetry Following Radioembolization with Resin Microspheres

(2014) Alexander S. Pasciak et al.   Frontiers in Oncology

Radioembolization and the Dynamic Role of 90Y PET/CT

(2014) Alexander S. Pasciak et al.   Frontiers in Oncology

Quantitative Monte Carlo-Based 90Y SPECT Reconstruction

(2013) M. Elschot et al.   JOURNAL OF NUCLEAR MEDICINE

Treatment Modification of Yttrium-90 Radioembolization Based on Quantitative Positron Emission Tomography/CT Imaging

(2013) Ted T. Chang et al.   JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY

3D inpatient dose reconstruction from the PET-CT imaging of 90 Y microspheres for metastatic cancer to the liver: Feasibility study

(2013) E. Fourkal et al.   MEDICAL PHYSICS

90Y microsphere therapy

(2013) Anand A. Zade et al.   NUCLEAR MEDICINE COMMUNICATIONS

Yttrium-90 Radioembolization for Hepatocellular Carcinoma: What We Know and What We Need to Know

(2013) Yun Hwan Kim et al.   ONCOLOGY

Post-radioembolization yttrium-90 PET/CT - part 2: dose-response and tumor predictive dosimetry for resin microspheres

(2013) Yung-Hsiang Kao et al.   EJNMMI Research

Post-radioembolization yttrium-90 PET/CT - part 1: diagnostic reporting

(2013) Yung-Hsiang Kao et al.   EJNMMI Research

Yttrium-90 radioembolization for intermediate-advanced hepatocellular carcinoma: A phase 2 study

(2012) Vincenzo Mazzaferro et al.   HEPATOLOGY

Hepatocellular carcinoma

(2012) Alejandro Forner et al.   LANCET

Quantitative 90 Y image reconstruction in PET

(2012) Kathy Willowson et al.   MEDICAL PHYSICS

90Y PET-based dosimetry after selective internal radiotherapy treatments

(2012) Marco D’Arienzo et al.   NUCLEAR MEDICINE COMMUNICATIONS

EASL and mRECIST responses are independent prognostic factors for survival in hepatocellular cancer patients treated with transarterial embolization

(2011) Roopinder Gillmore et al.   JOURNAL OF HEPATOLOGY

Recommendations of the American Association of Physicists in Medicine on dosimetry, imaging, and quality assurance procedures for 90 Y microsphere brachytherapy in the treatment of hepatic malignancies

(2011) William A. Dezarn et al.   MEDICAL PHYSICS

Radioembolization for hepatocellular carcinoma using TheraSphere®

(2011) SafiyyaMohamed Ali   Saudi Journal of Gastroenterology

Radioembolization Results in Longer Time-to-Progression and Reduced Toxicity Compared With Chemoembolization in Patients With Hepatocellular Carcinoma

(2010) Riad Salem et al.   GASTROENTEROLOGY

Efficacy and Toxicity Related to Treatment of Hepatocellular Carcinoma with 90Y-SIR Spheres: Radiobiologic Considerations

(2010) L. Strigari et al.   JOURNAL OF NUCLEAR MEDICINE

Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma

(2010) Riccardo Lencioni et al.   SEMINARS IN LIVER DISEASE

Yttrium-90 TOF PET scan demonstrates high-resolution biodistribution after liver SIRT

(2009) Renaud Lhommel et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Preoperative Y-90 microsphere selective internal radiation treatment for tumor downsizing and future liver remnant recruitment: a novel approach to improving the safety of major hepatic resections

(2009) Seza A Gulec et al.   World Journal of Surgical Oncology

Sorafenib in Advanced Hepatocellular Carcinoma

(2008) Josep M. Llovet et al.   NEW ENGLAND JOURNAL OF MEDICINE